NCT06647836View on ClinicalTrials.gov

The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Squamous Cell Lung Cancer
Interventions
OTHER

Efficacy observation

Observation about the efficacy of sq-NSCLC patients receiving immunotherapy combined with or without chemotherapy as first-line treatment.

Trial Locations (1)

430022

Union Hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER